Financhill
Back

Pharming Group Quote, Financials, Valuation and Earnings

Pharming Group Price Quote

$7.54
-0.50 (-6.22%)
(Updated: September 20, 2024 at 2:45 PM ET)

Pharming Group Key Stats

Buy
53
Pharming Group (PHAR) is a Buy

Day range:
$7.73 - $8.04
52-week range:
$6.65 - $16.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.29
P/B ratio:
2.47%

Volume:
4.5K
Avg. volume:
5.8K
1-year change:
-41.74%
Market cap:
$545.4M
Revenue:
$245.3M
EPS:
$-0.19

How Much Does Pharming Group Make?

Is Pharming Group Growing As A Company?

  • What Is Pharming Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.35%
  • What Is Pharming Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Pharming Group Stock Price Performance

  • Did Pharming Group Stock Go Up Last Month?
    Pharming Group share price went up by 0.75% last month
  • Did PHAR's Share Price Rise Over The Last Year?
    PHAR share price fell by -41.74% over the past 1 year

What Is Pharming Group 52-Week High & Low?

Pharming Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pharming Group?

  • How Much Debt Does Pharming Group Have?
    Total long term debt quarterly is $90.5M
  • How Much Cash Does Pharming Group Have?
    Cash and short term investments quarterly total is $160.3M
  • What Is Pharming Group’s Book Value Per Share?
    Book value per share is 3.26

Is Pharming Group Cash Flow Positive?

  • What Is PHAR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.8M
  • What Is Pharming Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$26.6M
  • What Is Pharming Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$25.1M

Pharming Group Return On Invested Capital

  • Is Management Doing A Good Job?
    PHAR return on invested capital is -3.95%
  • What Is Pharming Group Return On Assets?
    ROA measures how assets are converting to revenues and is -3.05%
  • What Is PHAR Return On Equity?
    ROE is a measure of profitability and is -6.31%

Pharming Group Earnings Date & Stock Price

Pharming Group Competitors

Pharming Group Dividend Yield

Pharming Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 50%
Revenue: 34.97% 2.91%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.00
Upside from Last Price: 322.89%

Major Shareholders

  • How many PHAR shares are owned by institutional investors?
    38.5M PHAR shares are owned by institutional investors
  • How many PHAR shares are owned by insiders?
    0 PHAR shares are owned by insiders